MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network - ScienceDirect
Fig. 4.1, Criteria to decide when the shorter MDR-TB regimen may be offered - WHO consolidated guidelines on drug-resistant tuberculosis treatment - NCBI Bookshelf
MULTIDRUG-RESISTANT TUBERCULOSIS (MDR-TB)
Building a treatment regimen for MDR-TB. | Download Scientific Diagram
WHO consolidated guidelines on drug-resistant tuberculosis treatment - NCBI Bookshelf
Tuberculosis management - Wikipedia
Drugs and doses used in shorter MDR regimen for patients older than 14... | Download Scientific Diagram
Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials | European Respiratory Society
Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling | Antimicrobial Agents and Chemotherapy
Drug resistant TB – latest developments in epidemiology, diagnostics and management - ScienceDirect
Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children | NEJM
New drugs and perspectives for new anti-tuberculosis regimens - ScienceDirect
Frontiers | Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country
Molecular TB
Annex. Summary of changes in policy on DS-TB treatment since 2010 and mapping of recommendations in consolidated DS-TB guidelines | TB Knowledge Sharing
Refining MDR-TB treatment regimens for ultra short therapy (TB-TRUST): study protocol for a randomized controlled trial | BMC Infectious Diseases | Full Text
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis | NEJM
![PDF] WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update: Applicability in South Korea | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/06b1491afd422ac031fced965478fa59ddecfe52/4-Table2-1.png "PDF] WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update: Applicability in South Korea | Semantic Scholar")
PDF] WHO Treatment Guidelines for Drug-Resistant Tuberculosis, 2016 Update: Applicability in South Korea | Semantic Scholar
Short-course BDQ-containing regimens. BDQ, bedaquiline; PO, oral... | Download Scientific Diagram
Frontiers | Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis - The Lancet Respiratory Medicine
Frontiers | Application of Next Generation Sequencing for Diagnosis and Clinical Management of Drug-Resistant Tuberculosis: Updates on Recent Developments in the Field
India: share of TB patients on treatment versus short MDR TB treatment regimen 2020 | Statista
Timeline of changes to trial design and release of WHO treatment guidelines | Download Scientific Diagram
All-oral longer regimens are effective for the management of multidrug-resistant tuberculosis in high-burden settings | European Respiratory Society
